Severity of Epilepsy and Response to Antiseizure Medications in Individuals With Multiple Sclerosis: Analysis of a Real-World Dataset

This study supports the notion that individuals with MS + E can have more severe epilepsy than those with E – MS. Seizure severity among individuals with MS + E treated with sodium channel blockers/modulators vs other ASM classes shows no significant differences. Classification of Evidence This study provides Class III evidence that individuals with MS + E can have more severe epilepsy than those with E – MS.
Source: Neurology Clinical Practice - Category: Neurology Authors: Tags: All Health Services Research, Multiple sclerosis, All epidemiology, All Epilepsy/Seizures, Antiepileptic drugs Research Article Source Type: research